Company: MBVI
Filing Date: 2025-07-02
Form Type: DRS
Source: 0001213900-25-060580
Chunk: 163

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-07-02
Form: DRS
Chunk 163
---
 non -managingsponsor investors reflecting interests in an aggregate of founder shares held by our sponsor. Membership interests reflecting interests in the remaining founder shares held by the sponsor will be held by the Sponsor Manager. The private placement warrants will also be worthless if we do not complete our initial business combination. The private placement warrants will be identical to the warrants sold in this offering except that, so long as they are held by our sponsor or its permitted transferees, the private placement warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (ii) will be entitled to registration rights and (iii) with respect to private placement warrants held by Cantor Fitzgerald & Co. and/or its designees, will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). We currently utilize office space at 1700 Broadway, 19 thFloor, New York, NY 10019 provided by an affiliate of our sponsor at no cost as our executive offices. Except as described herein, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these entities and individuals will be reimbursed for any out -of -pocketexpenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. In addition, we may pay consulting, success or finder fees to our independent directors, our advisors, or their respective affiliates in connection with the consummation of our initial business combination. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates. Prior to the closing of this offering, our sponsor may loan us funds in an aggregate amount of up to $300,000 to be used for a portion of the expenses of this offering. These loans would be non -interestbearing, unsecured and are due at the earlier of December 31, 2025 or the closing of this offering. As of June 10, 2025, we had no borrowings under the promissory note with our sponsor. In addition, in order to finance transaction costs in